Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $81.23 | $17.72 | 358.52% | 338.46x | 23.65x | 24.82x | 66.53x | 1.66x | $41.15M | 0.58% | $108.58M | 1.23 | $7.18B | 134.07 | ||
| CORT | CORCEPT THERAPEUTICS INC | $94.04 | $24.22 | 288.24% | 204.43x | 157.60x | 12.77x | 15.82x | 1.45x | $119.79M | 1.22% | $637.99M | 6.11 | $10.00B | -1,455.90 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $321.59 | $93.50 | 243.95% | 73.76x | 42.94x | 9.97x | 39.93x | 1.54x | $641.34M | 1.50% | $1.08B | 8.09 | $44.20B | 47.81 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.94 | $2.83 | 215.68% | 127.71x | 78.49x | 4.84x | 118.62x | 1.22x | $47.52M | 3.12% | $13.01M | 0.08 | $1.69B | 31.63 | ||
| HALO | HALOZYME THERAPEUTICS INC | $81.57 | $71.47 | 14.13% | 27.56x | 9.82x | 6.39x | 44.05x | 0.49x | $667.65M | 6.93% | $219.64M | 1.86 | $11.51B | 18.45 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $67.29 | $17.36 | 287.68% | 68.66x | 52.71x | 6.83x | 8.55x | 1.86x | $164.23M | 3.19% | $605.69M | 7.92 | $5.00B | 44.81 | ||
| KRYS | KRYSTAL BIOTECH INC | $368.60 | $95.58 | 285.66% | 47.56x | 47.09x | 25.87x | 8.51x | 2.27x | $237.38M | 2.20% | $1.28B | 43.59 | $10.37B | 48.49 | ||
| RPRX | ROYALTY PHARMA PLC | $57.80 | $39.97 | 44.62% | 30.26x | 10.84x | 10.35x | 3.35x | 0.65x | $2.34B | 9.27% | $9.94B | 22.75 | $41.65B | 35.80 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $60.35 | $40.44 | 49.24% | 43.11x | 16.33x | 3.58x | 1.88x | 0.61x | $767.06M | 6.60% | $6.21B | 32.27 | $10.02B | 20.77 | ||
| VCEL | VERICEL CORP | $46.95 | $9.16 | 412.81% | 109.19x | 97.39x | 8.16x | 6.73x | 2.30x | $47.49M | 1.99% | $356.23M | 7.02 | $2.38B | 58.96 | ||
| ADMA | ADMA BIOLOGICS INC | $9.21 | $9.22 | -0.12% | 13.35x | 10.98x | 4.26x | 5.47x | 0.56x | $107.90M | 4.96% | $390.33M | 1.65 | $2.19B | 9.91 | ||
| ASND | ASCENDIS PHARMA A | $266.97 | $81.03 | 229.46% | 28.30x | 18.18x | 16.28x | 28.88x | 2.88x | $52.94M | 0.32% | $574.09M | 9.24 | $16.96B | 181.90 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $247.72 | $49.25 | 402.95% | 527.06x | 9.58x | 3.45x | 3.43x | 1.78x | $1.30B | 8.46% | $4.53B | 73.22 | $19.10B | 28.30 | ||
| TGTX | TG THERAPEUTICS INC | $58.06 | $20.88 | 178.06% | 18.03x | 41.78x | 11.97x | 15.24x | 5.04x | -$14.19M | -0.17% | $583.13M | 4.04 | $9.20B | 61.31 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.26 | $35.89 | 6.61% | 15.12x | 10.48x | 2.46x | 2.43x | 0.57x | $341.79M | 15.45% | $910.35M | 15.75 | $1.78B | 7.53 | ||
| TECH | BIO-TECHNE CORP | $70.61 | $16.78 | 320.68% | 99.45x | 33.84x | 9.12x | 5.30x | 1.82x | $269.60M | 2.44% | $2.09B | 13.34 | $11.14B | 43.50 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $319.43 | $94.57 | 237.77% | 40.43x | 35.20x | 23.14x | 6.42x | 2.03x | $122.22M | 1.92% | $997.32M | 50.16 | $6.74B | 29.88 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.16 | $9.00 | -75.99% | 8.00x | -7.30x | 2.02x | 2.36x | 0.10x | $7.24M | 5.83% | $52.93M | 0.92 | $71.41M | 4.61 | ||
| EXEL | EXELIXIS INC | $57.08 | $31.16 | 83.21% | 18.29x | 17.54x | 6.21x | 7.41x | 1.31x | $917.69M | 6.22% | $1.94B | 7.49 | $14.29B | 13.53 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $522.25 | $168.28 | 210.35% | 30.70x | 26.72x | 10.86x | 6.85x | 2.24x | $3.71B | 2.80% | $19.36B | 76.20 | $129.04B | 23.93 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.45 | $2.46 | 39.98% | 14.38x | 14.58x | 2.11x | 3.34x | 0.97x | $4.11M | 1.48% | $82.33M | 1.03 | $210.80M | 9.92 | ||
| UTHR | UNITED THERAPEUTICS CORP | $563.70 | $242.28 | 132.67% | 19.25x | 20.30x | 7.74x | 4.05x | 2.16x | $1.02B | 4.15% | $5.90B | 135.66 | $22.65B | 13.22 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.49 | $12.81 | 145.76% | 17.40x | 15.81x | 6.45x | 3.81x | 3.26x | $208.13M | 5.40% | $1.01B | 8.28 | $3.10B | 9.26 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $676.23 | $436.73 | 54.84% | 15.89x | 14.36x | 4.71x | 2.26x | 1.07x | $4.11B | 5.85% | $31.42B | 302.15 | $70.64B | 12.30 | ||
| INCY | INCYTE CORP | $118.05 | $65.06 | 81.46% | 16.19x | 14.92x | 4.39x | 4.19x | 1.50x | $1.45B | 6.17% | $5.62B | 28.21 | $20.16B | 10.77 | ||
| VCYT | VERACYTE INC | $56.16 | $7.63 | 635.96% | 50.59x | 50.64x | 8.25x | 3.33x | 10.68x | $155.34M | 3.48% | $1.34B | 16.90 | $4.26B | 36.99 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $19.79 | $3.26 | 507.30% | 32.98x | 5.40x | 0.95x | 1.39x | 73.49x | $109.24M | 5.26% | $1.51B | 14.34 | $2.66B | 32.17 | ||
| MDXG | MIMEDX GROUP INC | $4.20 | $1.24 | 237.87% | 20.00x | -49.88x | 1.60x | 2.58x | 10.53x | $69.36M | 11.12% | $242.94M | 1.64 | $483.39M | 8.87 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.